Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal Cancer

DOI Full Paper Access

105

Citations

25

References

2016

Year

Jenny F. Seligmann, Faye Elliott, Susan D. Richman, Bart Jacobs, Gemma Hemmings, Sarah Brown, Jennifer H. Barrett, Sabine Tejpar, Philip Quirke

Abstract

isrctn Identifier: ISRCTN93248876.

References

	Year	Citations

Page 1